Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: What is their clinical relevance?

Epilepsy and Behavior

Volumn 20, Issue 1, 2011, Pages 146-

  Striano, Pasquale ^a   Errichiello, Luca ^b   Striano, Salvatore ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY;

BRAIN LEVEL; DISEASE COURSE; DISEASE MARKER; HUMAN; LETTER; NEUROPATHOLOGY; TEMPORAL LOBE EPILEPSY;

EID: 78651259624     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.10.006     Document Type: Letter

References (8)

1. Palace J., Lang B. Epilepsy: an autoimmune disease?. J Neurol Neurosurg Psychiatry 2000, 69:711-714.
2. Ranua J., Luoma K., Auvinen A., et al. Antimitochondrial antibodies in patients with epilepsy. Epilepsy Behav 2005, 7:95-97.
3. Saiz A., Blanco Y., Sabater L., et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
4. Stagg C.J., Lang B., Best J.G., et al. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia 2010, 51:1898-1901.
5. Batstra M.R., van Driel A., Petersen J.S., et al. Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values. Clin Chem 1999, 45:2269-2272.
6. Errichiello L., Perruolo G., Pascarella A., et al. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 2009, 211:120-123.
7. Kwan P., Sills G.J., Kelly K., Butler E., Brodie M.J. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 2000, 42:191-195.
8. Sokol D.K., McIntyre J.A., Wagenknecht D.R., et al. Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy. Neurology 2000, 62:517-518.